Sensei Biotherapeutics, Inc.
SNSE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | -$0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | -0% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | 93.4% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | 94.2% | – | – | – |
| EPS Diluted | -3.62 | -3.91 | -0.27 | -0.31 |
| % Growth | 7.4% | -1,348.1% | 12.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |